Pacific Edge Limited (NZE:PEB)
New Zealand · Delayed Price · Currency is NZD | Market Cap | 190.20M |
| Revenue (ttm) | 18.24M |
| Net Income (ttm) | -34.55M |
| Shares Out | 1.02B |
| EPS (ttm) | -0.04 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 360,395 |
| Average Volume | 675,263 |
| Open | 0.1870 |
| Previous Close | 0.1860 |
| Day's Range | 0.1860 - 0.1900 |
| 52-Week Range | 0.0550 - 0.2250 |
| Beta | 0.72 |
| RSI | 68.78 |
| Earnings Date | Feb 23, 2026 |
About Pacific Edge
Pacific Edge Limited, a cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients. It operates through two segments, Commercial and Research. The company offers Cxbladder, a genomic urine biomarker test for the detection and surveillance of bladder cancer. It also develops Cxbladder Triage, a frontline diagnostic product that helps de-intensify clinical work-up for patients with haematuria who have a low probability of bladder cancer; and Cxbladder Monitor, a non-inva... [Read more]
Financial Performance
In 2024, Pacific Edge's revenue was 22.75 million, a decrease of -9.83% compared to the previous year's 25.23 million. Losses were -29.94 million, 1.36% more than in 2023.
Financial StatementsNews
Pacific Edge Ltd (PFGTF) (Half Year 2026) Earnings Call Highlights: Navigating Challenges and ...
Pacific Edge Ltd (PFGTF) (Half Year 2026) Earnings Call Highlights: Navigating Challenges and Strategic Advances
Half Year 2026 Pacific Edge Ltd Earnings Call Transcript
Half Year 2026 Pacific Edge Ltd Earnings Call Transcript
Pacific Edge Limited (PFGTF) Q2 2026 Earnings Call Transcript
Pacific Edge Limited (OTCPK:PFGTF) Q2 2026 Earnings Call November 24, 2025 5:00 PM EST Company Participants Peter Meintjes - Chief Executive Officer Grant Gibson - Chief Financial Officer Conference C...
Half Year 2025 Pacific Edge Ltd Earnings Call Transcript
Half Year 2025 Pacific Edge Ltd Earnings Call Transcript